» Articles » PMID: 37435808

Neuronal Glutamate Transporters Control Reciprocal Inhibition and Gain Modulation in D1 Medium Spiny Neurons

Overview
Journal Elife
Specialty Biology
Date 2023 Jul 12
PMID 37435808
Authors
Affiliations
Soon will be listed here.
Abstract

Understanding the function of glutamate transporters has broad implications for explaining how neurons integrate information and relay it through complex neuronal circuits. Most of what is currently known about glutamate transporters, specifically their ability to maintain glutamate homeostasis and limit glutamate diffusion away from the synaptic cleft, is based on studies of glutamate transporters. By contrast, little is known about the functional implications of glutamate transporters. The neuronal glutamate transporter EAAC1 is widely expressed throughout the brain, particularly in the striatum, the primary input nucleus of the basal ganglia, a region implicated with movement execution and reward. Here, we show that EAAC1 limits synaptic excitation onto a population of striatal medium spiny neurons identified for their expression of D1 dopamine receptors (D1-MSNs). In these cells, EAAC1 also contributes to strengthen lateral inhibition from other D1-MSNs. Together, these effects contribute to reduce the gain of the input-output relationship and increase the offset at increasing levels of synaptic inhibition in D1-MSNs. By reducing the sensitivity and dynamic range of action potential firing in D1-MSNs, EAAC1 limits the propensity of mice to rapidly switch between behaviors associated with different reward probabilities. Together, these findings shed light on some important molecular and cellular mechanisms implicated with behavior flexibility in mice.

Citing Articles

Striatal insights: a cellular and molecular perspective on repetitive behaviors in pathology.

Burton C, Longaretti A, Zlatanovic A, Gomes G, Tonini R Front Cell Neurosci. 2024; 18:1386715.

PMID: 38601025 PMC: 11004256. DOI: 10.3389/fncel.2024.1386715.


Forebrain EAAT3 Overexpression Increases Susceptibility to Amphetamine-Induced Repetitive Behaviors.

Kopelman J, Chohan M, Hsu A, Yttri E, Veenstra-VanderWeele J, Ahmari S eNeuro. 2024; 11(4).

PMID: 38514191 PMC: 11012153. DOI: 10.1523/ENEURO.0090-24.2024.


Morphological changes in perisynaptic astrocytes induced by dopamine neuronal degeneration in the striatum of rats.

Sun L, Zheng X, Che Y, Zhang Y, Huang Z, Jia L Heliyon. 2024; 10(6):e27637.

PMID: 38510046 PMC: 10950654. DOI: 10.1016/j.heliyon.2024.e27637.


Neuronal glutamate transporters control reciprocal inhibition and gain modulation in D1 medium spiny neurons.

Petroccione M, DBrant L, Affinnih N, Wehrle P, Todd G, Zahid S Elife. 2023; 12.

PMID: 37435808 PMC: 10411972. DOI: 10.7554/eLife.81830.

References
1.
Welch J, Lu J, Rodriguiz R, Trotta N, Peca J, Ding J . Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature. 2007; 448(7156):894-900. PMC: 2442572. DOI: 10.1038/nature06104. View

2.
Abramowitz J, Taylor S, McKay D . Obsessive-compulsive disorder. Lancet. 2009; 374(9688):491-9. DOI: 10.1016/S0140-6736(09)60240-3. View

3.
Kingston A, Ornstein P, Wright R, Johnson B, Mayne N, Burnett J . LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology. 1998; 37(1):1-12. DOI: 10.1016/s0028-3908(97)00191-3. View

4.
Shmelkov S, Hormigo A, Jing D, Proenca C, Bath K, Milde T . Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice. Nat Med. 2010; 16(5):598-602, 1p following 602. PMC: 2907076. DOI: 10.1038/nm.2125. View

5.
Menzies L, Williams G, Chamberlain S, Ooi C, Fineberg N, Suckling J . White matter abnormalities in patients with obsessive-compulsive disorder and their first-degree relatives. Am J Psychiatry. 2008; 165(10):1308-15. DOI: 10.1176/appi.ajp.2008.07101677. View